Lv3
283 积分 2021-03-25 加入
STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPY
2天前
已完结
Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer
5天前
已完结
A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort
6天前
已完结
Association of childhood maltreatment with risk of lung cancer: A mediation analysis from the UK biobank
6天前
已完结
Molecular and Clinical Characteristics of Patients with Non–Small Cell Lung Cancer Harboring KRAS G12V Mutations
21天前
已完结
Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non–Small Cell Lung Cancer
21天前
已完结
The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and its Genomic Analysis
21天前
已完结
Cytotoxic CD39 + tumor-associated NK cells respond to NKG2A blockade in lung cancer
21天前
已完结
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses
21天前
已关闭
Multidimensional proteomics and explainable AI feature selection identify cross-platform lung cancer molecular signature in blood plasma
22天前
已关闭
皖公网安备34019202002308
